| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64950-359-04 | 64950-359 | HUMAN PRESCRIPTION DRUG | GOPRELTO | cocaine hydrochloride | SOLUTION | NASAL | 20180108 | N/A | NDA | NDA209963 | Genus Lifesciences Inc. | COCAINE HYDROCHLORIDE | 40 mg/mL | 1 BOTTLE, GLASS in 1 CARTON (64950-359-04) / 4 mL in 1 BOTTLE, GLASS |
| 64950-362-04 | 64950-362 | HUMAN PRESCRIPTION DRUG | cocaine hydrochloride | cocaine hydrochloride | SOLUTION | NASAL | 20180604 | 20250531 | NDA AUTHORIZED GENERIC | NDA209963 | Genus Lifesciences Inc. | COCAINE HYDROCHLORIDE | 40 mg/mL | 1 BOTTLE, GLASS in 1 CARTON (64950-362-04) / 4 mL in 1 BOTTLE, GLASS |
| 70839-362-04 | 70839-362 | HUMAN PRESCRIPTION DRUG | COCAINE HYDROCHLORIDE | COCAINE HYDROCHLORIDE | SOLUTION | NASAL | 20240129 | N/A | NDA AUTHORIZED GENERIC | NDA209963 | LXO US INC. | COCAINE HYDROCHLORIDE | 40 mg/mL | 1 BOTTLE, GLASS in 1 CARTON (70839-362-04) / 4 mL in 1 BOTTLE, GLASS |